The involvement of secondary neuronal damage in the development of neuropsychiatric disorders following brain insults

Frontiers in Neurology

Volumn 5 MAR, Issue , 2014, Pages

  Chen, Yun ^a   Garcia, Gregory E ^b   Huang, Wei ^c   Constantini, Shlomi ^d  

^a BrightstarTech Inc   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Brain insults; Clinical manifestations; Histomorphology; Neurodegenerative diseases; Neuropsychiatric disorders; Pathophysiology; Secondary neuronal damage; Traumatic brain injury

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID; ACETONE; ACETYLCHOLINESTERASE; BENZENE; CALCIUM; CANNABIS; CHEMICAL WARFARE AGENT; COCAINE; CYCLOSARIN; DOPAMINE; GLUTAMIC ACID; ILLICIT DRUG; LEAD; MERCURY; METHAMPHETAMINE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; NORADRENALIN; ORGANOPHOSPHATE PESTICIDE; SARIN; SEROTONIN; SOMAN; STRYCHNINE; TABUN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; ALCOHOL ABUSE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANGER; APHASIA; APOPTOSIS; ARTICLE; AUTOREGULATION; BASAL GANGLION; BIPOLAR DISORDER; BLAST INJURY; BLURRED VISION; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN SIZE; BRAIN STEM; CALCIUM TRANSPORT; CEREBELLUM; CEREBROVASCULAR ACCIDENT; CHOLINERGIC SYSTEM; CHRONIC DISEASE; CLOSED HEAD INJURY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONSCIOUSNESS DISORDER; COORDINATION DISORDER; CYTOTOXICITY; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; ENZYME INHIBITION; FATIGUE; HALLUCINATION; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; HYPOPHYSIS ADENOMA; INFLAMMATION; IRRITABILITY; LEARNING DISORDER; LIMBIC SYSTEM; MANIA; MEMORY DISORDER; MENTAL DISEASE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NAUSEA; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NERVE INJURY; NERVE SHEATH TUMOR; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PSYCHOMOTOR RETARDATION; SEIZURE; SLEEP DISORDER; SOMATOFORM DISORDER; STREPTOCOCCUS INFECTION; SUICIDE; TREMOR; VISUAL FIELD DEFECT; VOMITING;

EID: 84897993228     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00022     Document Type: Article

References (139)

1. Hyman SE, Chisholm D, Kessler R, Patel V, Whiteford H. Mental disorders. 2nd ed. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. Washington, DC: World Bank (2006). p. 605-26.
2. The World Health Organization. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ (2000) 78:413-26.
3. Sherer R. Mental health care in the developing world. Psychiatric Times (2002) 19:1-6.
4. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 62:593-602. doi: 10.1001/archpsyc.62.6.617
5. The World Health Organization. Mental Health New Understanding, New Hope. The World Health Report 2001. (2001). Available from: http://www.who.int/whr/2001/en/
6. Ostman M, Kjellin L. Stigma by association: psychological factors in relatives of people with mental illness. Br J Psychiatry (2002) 181:494-8. doi:10.1192/bjp.181.6.494
7. Kinderman P. A psychological model of mental disorder. Harv Rev Psychiatry (2005) 13:206-17. doi:10.1080/10673220500243349
8. Rutter M. How the environment affects mental health. Br J Psychiatry (2005) 186:4-6. doi:10.1192/bjp.186.1.4
9. Schmidt CW. Environmental connections: a deeper look into mental illness. Environ Health Perspect (2007) 115:A404-10. doi:10.1289/ehp.115-a404
10. Ahn WK, Proctor CC, Flanagan EH. Mental health clinicians' beliefs about the biological, psychological, and environmental bases of mental disorders. Cogn Sci (2009) 33:147-82. doi:10.1111/j.1551-6709.2009.01008.x
11. Blair RJ. The neurobiology of psychopathic traits in youths. Nat Rev Neurosci (2013) 14:786-99. doi:10.1038/nrn3577
12. Sledzik PS, Bellantoni N. Brief communication: bioarcheological and biocultural evidence for the New England vampire folk belief. Am J Phys Anthropol (1994) 94:269-74. doi:10.1002/ajpa.1330940210
13. Chen Y, Huang W, Constantini S. Concepts and strategies for clinical management of blast-induced traumatic brain injury and posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci (2013) 25:103-10. doi:10.1176/appi.neuropsych.12030058
14. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E. An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma (1996) 13:557-68.
15. Chen Y, Huang W, Constantini S. The differences between blast-induced and sports-related brain injuries. Front Neurol (2013) 4:119. doi:10.3389/fneur.2013.00119
16. Chen Y, Huang W. Non-impact, blast-induced mild TBI and PTSD: concepts and caveats. Brain Inj (2011) 25:641-50. doi:10.3109/02699052.2011.580313
17. Donnan GA, Fisher M, MacLeod M, Davis SM. Stroke. Lancet (2008) 371:1612-23. doi:10.1016/S0140-6736(08)60694-7
18. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta (2010) 1802:80-91. doi:10.1016/j.bbadis.2009.09.003
19. Chen Y. Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology (2012) 33:391-400. doi:10.1016/j.neuro.2012.03.011
20. Eckert WG. Mass deaths by gas or chemical poisoning. A historical perspective. Am J Forensic Med Pathol (1991) 12:119-25. doi:10.1097/00000433-199106000-00007
21. Cullen J. Avoiding chemical poisoning. Nurs N Z (1996) 2:20-1.
22. Schaumburg HH, Spencer PS. Recognizing neurotoxic disease. Neurology (1987) 37:276-8. doi:10.1212/WNL.37.2.276
23. Tilson HA, Kodavanti PR, Mundy WR, Bushnell PJ. Neurotoxicity of environmental chemicals and their mechanism of action. Toxicol Lett (1998) 10(2-103):631-5. doi:10.1016/S0378-4274(98)00271-9
24. Morimoto K, Hooper DC, Bornhorst A, Corisdeo S, Bette M, Fu ZF, et al. Intrinsic responses to Borna disease virus infection of the central nervous system. Proc Natl Acad Sci U S A (1996) 93:13345-50. doi:10.1073/pnas.93.23.13345
25. Reinvang I, Frøland SS, Skripeland V. Prevalence of neuropsychological deficit in HIV infection. Incipient signs of AIDS dementia complex in patients with AIDS. Acta Neurol Scand (1991) 83:289-93. doi:10.1111/j.1600-0404.1991.tb04703.x
26. Merrill JE, Chen IS. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J (1991) 5:2391-7.
27. Pulliam L, Clarke JA, McGuire D, McGrath MS. Investigation of HIV-infected macrophage neurotoxin production from patients with AIDS dementia. Adv Neuroimmunol (1994) 4:195-8. doi:10.1016/S0960-5428(06)80257-3
28. Moretti G, Pasquini M, Mandarelli G, Tarsitani L, Biondi M. What every psychiatrist should know about PANDAS: a review. Clin Pract Epidemiol Ment Health (2008) 4:13. doi:10.1186/1745-0179-4-13
29. Martino D, Defazio G, Giovannoni G. The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res (2009) 67:547-57. doi:10.1016/j.jpsychores.2009.07.004
30. de Oliveira SK, Pelajo CF. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep (2010) 12:103-9. doi:10.1007/s11908-010-0082-7
31. Snyder H, Robinson K, Shah D, Brennan R, Handrigan M. Signs and symptoms of patients with brain tumors presenting to the emergency department. J Emerg Med (1993) 11:253-8. doi:10.1016/0736-4679(93)90042-6
32. Constantini S, Tamir J, Gomori MJ, Shohami E. Tumor prostaglandin levels correlate with edema around meningiomas. Neurosurgery (1993) 33:204-11. doi:10.1097/00006123-199308000-00004
33. Jarquin-Valdivia AA. Psychiatric symptoms and brain tumors: a brief historical overview. Arch Neurol (2004) 61:1800-4. doi:10.1001/archneur.61.11.1800
34. Roth J, Keating RF, Myseros JS, Yaun AL, Magge SN, Constantini S. Pediatric incidental brain tumors: a growing treatment dilemma. J Neurosurg Pediatr (2012) 10:168-74. doi:10.3171/2012.6.PEDS11451
35. Bellows JG. Alcohol abuse and brain damage. Compr Ther (1979) 5:3-5.
36. Ward RJ, Lallemand F, de Witte P. Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse. Alcohol Alcohol (2009) 44:128-35. doi:10.1093/alcalc/agn100
37. Nail RL, Dean LM. Drug abuse: a manifestation of the cyclic nature of human behavior. Drug Alcohol Depend (1976) 1:429-34. doi:10.1016/0376-8716(76)90007-7
38. Schulden JD, Lopez MF, Compton WM. Clinical implications of drug abuse epidemiology. Psychiatr Clin North Am (2012) 35:411-23. doi:10.1016/j.psc.2012.03.007
39. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD. (2012). Available from: http://www.samhsa.gov/data/nsduh/2k11results/nsduhresults2011.htm#Ch2
40. Gordon HW. Early environmental stress and biological vulnerability to drug abuse. Psychoneuroendocrinology (2002) 27:115-26. doi:10.1016/S0306-4530(01)00039-7
41. Miczek KA, Yap JJ, Covington HE III. Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther (2006) 120:102-28. doi:10.1016/j.pharmthera.2008.07.006
42. De La Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, et al. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit (2004) 26:137-44. doi:10.1097/00007691-200404000-00009
43. Bolla KI, McCann UD, Ricaurte GA. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology (1998) 51:1532-7. doi:10.1212/WNL.51.6.1532
44. Fattore L, Piras G, Corda MG, Giorgi O. The Roman high- and low-avoidance rat lines differ in the acquisition, maintenance, extinction, and reinstatement of intravenous cocaine self-administration. Neuropsychopharmacology (2009) 34:1091-101. doi:10.1038/npp.2008.43
45. Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1999) 11:361-9.
46. Bolla KI, Funderburk FR, Cadet JL. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology (2000) 54:2285-92. doi:10.1212/WNL.54.12.2285
47. Planeta CS, Lepsch LB, Alves R, Scavone C. Influence of the dopaminergic system, CREB, and transcription factor-?B on cocaine neurotoxicity. Braz J Med Biol Res (2013) 46:909-15. doi:10.1590/1414-431X20133379
48. Malenka RC, Nestler EJ, Hyman SE. Unlike cocaine and amphetamine, methamphetamine is directly toxic to midbrain dopamine neurons. 2nd ed. In: Sydor A, Brown RY editors. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. New York: McGraw-Hill (2009). 370 p.
49. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev (2008) 27:253-62. doi:10.1080/09595230801923702
50. Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage (2005) 26:480-92. doi:10.1016/j.neuroimage.2005.02.012
51. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology (2002) 59:1337-43. doi:10.1212/01.WNL.0000031422.66442.49
52. Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann Neurol (1993) 33:267-74. doi:10.1002/ana.410330307
53. Stern Y, Richards M, Sano M, Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol (1993) 50:1040-5. doi:10.1001/archneur.1993.00540100035011
54. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet (2004) 363:1783-93. doi:10.1016/S0140-6736(04)16305-8
55. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry (2008) 79:368-76. doi:10.1136/jnnp.2007.131045
56. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci (1998) 18:2801-7.
57. Gold CA, Budson AE. Memory loss in Alzheimer's disease: implications for development of therapeutics. Expert Rev Neurother (2008) 8:1879-91. doi:10.1586/14737175.8.12.1879
58. Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology (2004) 62:1984-9. doi:10.1212/01.WNL.0000129697.01779.0A
59. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol (2007) 6:994-1003. doi:10.1016/S1474-4422(07)70265-X
60. Chio A, Calvo A, Moglia C, Mazzini L, Mora G Parals Study Group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry (2011) 82:740-6. doi:10.1136/jnnp.2010.235952
61. Young AB. Role of excitotoxins in heredito-degenerative neurologic diseases. Res Publ Assoc Res Nerv Ment Dis (1993) 71:175-89.
62. Young AB. Impairment of energy metabolism and excitotoxic cell death in Huntington disease. Rev Neurol (Paris) (1997) 153:496-8.
63. Walker FO. Huntington's disease. Lancet (2007) 369:218-28. doi:10.1016/S0140-6736(07)60111-1
64. Berent S, Giordani B, Lehtinen S, Markel D, Penney JB, Buchtel HA, et al. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Ann Neurol (1988) 23:541-6. doi:10.1002/ana.410230603
65. Montoya A, Price BH, Menear M, Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci (2006) 31:21-9.
66. Paulsen JS, Smith MM, Long JD PREDICT HD investigators, Coordinators of the Huntington Study Group. Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry (2013) 84:1233-9. doi:10.1136/jnnp-2013-305114
67. Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and Forest plots using a Microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes (2012) 5:52. doi:10.1186/1756-0500-5-52
68. Kronish IM, Edmondson D, Goldfinger JZ, Fei K, Horowitz CR. Posttraumatic stress disorder and adherence to medications in survivors of strokes and transient ischemic attacks. Stroke (2012) 43:2192-7. doi:10.1161/STROKEAHA.112.655209
69. Bruce M, Gumley D, Isham L, Fearon P, Phipps K. Post-traumatic stress symptoms in childhood brain tumour survivors and their parents. Child Care Health Dev (2011) 37:244-51. doi:10.1111/j.1365-2214.2010.01164.x
70. Kawana N, Ishimatsu S, Kanda K. Psycho-physiological effects of the terrorist sarin attack on the Tokyo subway system. Mil Med (2001) 166:23-6.
71. Yoshihara Y, Sugihara G, Matsumoto H, Suckling J, Nishimura K, Toyoda T, et al. Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann Gen Psychiatry (2008) 7:25. doi:10.1186/1744-859X-7-25
72. Matthews PR, Harrison PJ. A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide. J Affect Disord (2012) 137:125-34. doi:10.1016/j.jad.2011.10.043
73. Holleran L, Ahmed M, Anderson-Schmidt H, McFarland J, Emsell L, Leemans A, et al. Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia. Neuropsychopharmacology (2013) 39:944-54. doi:10.1038/npp.2013.294
74. Takei Y, Suda M, Aoyama Y, Yamaguchi M, Sakurai N, Narita K, et al. Temporal lobe and inferior frontal gyrus dysfunction in patients with schizophrenia during face-to-face conversation: a near-infrared spectroscopy study. J Psychiatr Res (2013) 47:1581-9. doi:10.1016/j.jpsychires.2013.07.029
75. Lim HK, Jung WS, Aizenstein HJ. Aberrant topographical organization in gray matter structural network in late life depression: a graph theoretical analysis. Int Psychogeriatr (2013) 25:1929-40. doi:10.1017/S104161021300149X
76. Willard SL, Riddle DR, Forbes ME, Shively CA. Cell number and neuropil alterations in subregions of the anterior hippocampus in a female monkey model of depression. Biol Psychiatry (2013) 74:890-7. doi:10.1016/j.biopsych.2013.03.013
77. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry (2008) 65:1017-32. doi:10.1001/archpsyc.65.9.1017
78. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry. (2009) 195:194-201. doi:10.1192/bjp.bp.108.059717
79. Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KD, et al. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord (2012) 14:313-25. doi:10.1111/j.1399-5618.2012.01022.x
80. Büttner A, Kroehling C, Mall G, Penning R, Weis S. Alterations of the vascular basal lamina in the cerebral cortex in drug abuse: a combined morphometric and immunohistochemical investigation. Drug Alcohol Depend (2005) 79:63-70. doi:10.1016/j.drugalcdep.2004.12.010
81. Büttner A. Review: the neuropathology of drug abuse. Neuropathol Appl Neurobiol (2011) 37:118-34. doi:10.1111/j.1365-2990.2010.01131.x
82. Vertes RP. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience (2006) 142:1-20. doi:10.1016/j.neuroscience.2006.06.027
83. Grossberg S. Adaptive Resonance Theory: how a brain learns to consciously attend, learn, and recognize a changing world. Neural Netw (2013) 37:1-47. doi:10.1016/j.neunet.2012.09.017
84. Satterthwaite TD, Wolf DH, Loughead J, Ruparel K, Valdez JN, Siegel SJ, et al. Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia. Am J Psychiatry (2010) 167:418-26. doi:10.1176/appi.ajp.2009.09060808
85. Passarotti AM, Sweeney JA, Pavuluri MN. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder. Psychopharmacology (Berl) (2011) 216:485-99. doi:10.1007/s00213-011-2243-2
86. Fix JD. Basal ganglia and the striatal motor system. In: Wilkins WKLW, editor. Neuroanatomy (Board Review Series). 4th ed. Baltimore: Wolters Kluwer & Lippincott Williams & Wilkins (2008). p. 274-81.
87. van der Stelt M, Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol (2003) 480:133-50. doi:10.1016/j.ejphar.2003.08.101
88. Rothwell JC. The motor functions of the basal ganglia. J Integr Neurosci (2011) 10:303-15. doi:10.1142/S0219635211002798
89. Wolf U, Rapoport MJ, Schweizer TA. Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci (2009) 21:245-53. doi:10.1176/appi.neuropsych.21.3.245
90. Fine EJ, Ionita CC, Lohr L. The history of the development of the cerebellar examination. Semin Neurol (2002) 22:375-84. doi:10.1055/s-2002-36759
91. Bowen DM, Najlerahim A, Procter AW, Francis PT, Murphy E. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc Natl Acad Sci U S A (1989) 86:9504-8. doi:10.1073/pnas.86.23.9504
92. de Courten-Myers GM. The human cerebral cortex: gender differences in structure and function. J Neuropathol Exp Neurol (1999) 58:217-26. doi:10.1097/00005072-199903000-00001
93. Sumitomo I, Hayashi Y. Electrical responses of cat superior colliculus in reticular formation activation and during natural sleep-wakefulness cycle. Tohoku J Exp Med (1967) 91:13-30. doi:10.1620/tjem.91.13
94. Ishizawa Y, Ma HC, Dohi S, Shimonaka H. Effects of cholinomimetic injection into the brain stem reticular formation on halothane anesthesia and antinociception in rats. J Pharmacol Exp Ther (2000) 293:845-51.
95. Hill DL, Almli CR. Midbrain reticular formation damage and the ontogeny of ingestive and sensorimotor behaviors. Physiol Behav (1981) 26:269-75. doi:10.1016/0031-9384(81)90022-6
96. Jordan WP, Leaton RN. Habituation of the acoustic startle response in rats after lesions in the mesencephalic reticular formation or in the inferior colliculus. Behav Neurosci (1983) 97:710-24. doi:10.1037/0735-7044.97.5.710
97. Szymusiak R, McGinty D. Sleep suppression following kainic acid-induced lesions of the basal forebrain. Exp Neurol (1986) 94:598-614. doi:10.1016/0014-4886(86)90240-2
98. Sharma R, Engemann SC, Sahota P, Thakkar MM. Effects of ethanol on extracellular levels of adenosine in the basal forebrain: an in vivo microdialysis study in freely behaving rats. Alcohol Clin Exp Res (2010) 34:813-8. doi:10.1111/j.1530-0277.2010.01153.x
99. Neumann MA, Eger EI II, Weiskopf RB. Solubility of volatile anesthetics in bovine white matter, cortical gray matter, thalamus, hippocampus, and hypothalamic area. Anesth Analg (2005) 100:1003-6. doi:10.1213/01.ANE.0000146516.35921.1A
100. Jellinger KA. Functional pathophysiology of consciousness. Neuropsychiatr (2009) 23:115-33.
101. Oyama O, Paltoo C, Greengold J. Somatoform disorders. Am Fam Physician (2007) 76:1333-8.
102. Kreipe RE. The biopsychosocial approach to adolescents with somatoform disorders. Adolesc Med Clin (2006) 17:1-24.
103. Stein DJ, Muller J. Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualizing the triad of depression anxiety-somatic symptoms. CNS Spectr (2008) 13:379-84.
104. García-Campayo J, Fayed N, Serrano-Blanco A, Roca M. Brain dysfunction behind functional symptoms: neuroimaging and somatoform, conversive, and dissociative disorders. Curr Opin Psychiatry (2009) 22:224-31. doi:10.1097/YCO.0b013e3283252d43
105. Farrugia D, Fetter H. Chronic pain: biological understanding and treatment suggestions for mental health counselors. J Ment Health Couns (2009) 31:189-200.
106. Katzer A, Oberfeld D, Hiller W, Gerlach AL, Witthöft M. Tactile perceptual processes and their relationship to somatoform disorders. J Abnorm Psychol (2012) 121:530-43. doi:10.1037/a0026536
107. Widlöcher DJ. Psychomotor retardation: clinical, theoretical, and psychometric aspects. Psychiatr Clin North Am (1983) 6:27-40.
108. King DJ. Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatr Scand Suppl (1994) 380:53-8. doi:10.1111/j.1600-0447.1994.tb05833.x
109. Pier MP, Hulstijn W, Sabbe BG. Psychomotor retardation in elderly depressed patients. J Affect Disord (2004) 81:73-7. doi:10.1016/j.jad.2003.08.002
110. Zohar O, Rubovitch V, Milman A, Schreiber S, Pick CG. Behavioral consequences of minimal traumatic brain injury in mice. Acta Neurobiol Exp (Wars) (2011) 71:36-45.
111. Stevens MC, Lovejoy D, Kim J, Oakes H, Kureshi I, Witt ST. Multiple resting state network functional connectivity abnormalities in mild traumatic brain injury. Brain Imaging Behav (2012) 6:293-318. doi:10.1007/s11682-012-9157-4
112. Frackowiak RS, Weiller C, Chollet F. The functional anatomy of recovery from brain injury. Ciba Found Symp (1991) 163:235-44.
113. Abu-Judeh HH, Parker R, Singh M, el-Zeftawy H, Atay S, Kumar M, et al. SPET brain perfusion imaging in mild traumatic brain injury without loss of consciousness and normal computed tomography. Nucl Med Commun (1999) 20:505-10. doi:10.1097/00006231-199906000-00003
114. Slobounov S, Sebastianelli W, Moss R. Alteration of posture-related cortical potentials in mild traumatic brain injury. Neurosci Lett (2005) 383:251-5. doi:10.1016/j.neulet.2005.04.039
115. Parent A, Carpenter MB. Carpenter's Human Neuroanatomy. 9th ed. Philadelphia: Lippincott Williams & Wilkins (1995). p. 186-92.
116. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience (2004) 129:1021-9. doi:10.1016/j.neuroscience.2004.06.046
117. Bothe HW, Bodsch W, Hossmann KA. Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema. Acta Neuropathol (1984) 64:37-42. doi:10.1007/BF00695604
118. Agrawal SK, Fehlings MG. Mechanisms of secondary injury to spinal cord axons in vitro: role of Na+, Na(+)-K(+)-ATPase, the Na(+)-H+ exchanger, and the Na(+)-Ca2+ exchanger. J Neurosci (1996) 16:545-52.
119. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care (2002) 8:101-5. doi:10.1097/00075198-200204000-00002
120. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci (2001) 2:734-44. doi:10.1038/35094583
121. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 4:399-415. doi:10.1038/nrn1106
122. Frank MG, Barrientos RM, Thompson BM, Weber MD, Watkins LR, Maier SF. IL-1RA injected intra-cisterna magna confers extended prophylaxis against lipopolysaccharide-induced neuroinflammatory and sickness responses. J Neuroimmunol (2012) 252:33-9. doi:10.1016/j.jneuroim.2012.07.010
123. Pucak ML, Carroll KA, Kerr DA, Kaplin AI. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci (2007) 9:125-39.
124. Chen J, Wersinger C, Sidhu A. Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity. J Biol Chem (2003) 278:28089-100. doi:10.1074/jbc.M303094200
125. Clement JG, Broxup B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicology (1993) 14:485-504.
126. Siesjo BK, Siesjo P. Mechanisms of secondary brain injury. Eur J Anaesthesiol (1996) 13:247-68. doi:10.1097/00003643-199605000-00004
127. Nagatsu T, Sawada M. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm Suppl (2007) 72:113-20. doi:10.1007/978-3-211-73574-9_14
128. Gil-Bea FJ, García-Alloza M, Domínguez J, Marcos B, Ramírez MJ. Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit. Neurosci Lett (2005) 375:37-41. doi:10.1016/j.neulet.2004.10.062
129. Wilson JM, Khabazian I, Pow DV, Craig UK, Shaw CA. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC. Neuromolecular Med (2003) 3:105-18. doi:10.1385/NMM:3:2:105
130. Seifert T, Secher NH. Sympathetic influence on cerebral blood flow and metabolism during exercise in humans. Prog Neurobiol (2011) 95:406-26. doi:10.1016/j.pneurobio.2011.09.008
131. Strebel S, Lam AM, Matta BF, Newell DW. Impaired cerebral autoregulation after mild brain injury. Surg Neurol (1997) 47:128-31. doi:10.1016/S0090-3019(96)00459-4
132. Khan T, Waring P. Macrophage adherence prevents apoptosis induced by ricin. Eur J Cell Biol (1993) 62:406-14.
133. Tang DG, Porter AT. Apoptosis: a current molecular analysis. Pathol Oncol Res (1996) 2:117-31. doi:10.1007/BF02903515
134. Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J Biol Chem (2006) 281:5612-22. doi:10.1074/jbc.M507213200
135. Franzen CA, Chen CC, Todorovic V, Juric V, Monzon RI, Lau LF. Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis. Mol Cancer Res (2009) 7:1045-55. doi:10.1158/1541-7786.MCR-09-0017
136. Conti AC, Raghupathi R, Trojanowski JQ, McIntosh TK. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci (1998) 18:5663-72.
137. Ng I, Yeo TT, Tang WY, Soong R, Ng PY, Smith DR. Apoptosis occurs after cerebral contusions in humans. Neurosurgery (2000) 46:949-56. doi:10.1227/00006123-200004000-00034
138. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg (2005) 18:335-50. doi:10.1080/08941930500328862
139. Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations in the use of the Glasgow outcome scale. J Neurol Neurosurg Psychiatry (1981) 44:285-93. doi:10.1136/jnnp.44.4.285